²é¿´: 3020  |  »Ø¸´: 15

johozhang

½ð³æ (СÓÐÃûÆø)

[½»Á÷] ÌûÒ»¸öNSFµÄÆÀÉó±ê×¼£¬Í¬Ê±Îª×Ô¼ºµÄÇà»ùÆí¸££¡ ÒÑÓÐ15È˲ÎÓë

Belows are the reviewing guidelines:

¡°What is the intellectual merit of the proposed activity?¡±

-  Does the proposal have a sound approach to establish technical and commercial feasibility?

-  Does the proposal suggest and explore unique or ingenious concepts or applications? Please note that an innovation can be interpreted as providing a novel commercial product to the marketplace that meets a critical need.

-  Does the team have the qualifications to carry out the work plan?

-  Does the company have sufficient access to resources, such as materials, supplies, analytical services, equipment, facilities, etc., to carry out the work plan?

-  Does the proposed project reflect revolutionary advances in the field?

¡°What are the broader impacts of the proposed activity?¡±

-  What would be the commercial and/or societal benefits of this project, if successful?

-  Would this project lead to a marketable product or process?

-  What is the competitive advantage of the proposed concept?

-  Could this project lead to enabling technologies?

-  If successful, could this project attract funding from non-SBIR sources?

-  Does the business team possess the relevant skills to commercialize the proposed innovation?

-  If the company has received previous SBIR or STTR funding, please review the Company¡¯s Commercialization History (found in the Supplementary Documents module) and comment on the percentage of the revenues from previous SBIR/STTR funding.

-  If the project broadens the participation of underrepresented groups, please comment on it.

¡°Summary Statement¡±

-  Summarize your overall evaluation of the proposal.


I would also like to list the funding criteria of NSF SBIR/STTR program as below for your reference.

-  Must be high-risk and high-payback innovations with high commercial potentials.

-  Demonstrate strategic partnerships with research collaborators, customers and equity investors.


NSF do NOT fund,

-  Basic research projects.

-  Evolutionary optimization of existing products and processes or modifications to broaden the scope of an existing product, process or application.

-  Analytical or market studies of technologies.

-  Clinical trials.

*****************************

You don't need to address every questions, your most important parts are to indicate the strengths and weakness of the proposal, then rank the proposal as (one of them)
Excellent
Very good
Good
Fair
Poor
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hblgczy

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ʲô»ù½ðѽ£¬»¹ÊÇÓ¢Îİæ
ÓÐÖ¾Õߣ¬Ê¾¹³É£¬ÆÆ¸ª³ÁÖÛ£¬°Ù¶þÇØ¹ØÖÕÊô³þ£»¿àÐÄÈË£¬Ìì²»¸º£¬ÎÔн³¢µ¨£¬ÈýǧԽ¼×¿ÉÍÌÎâ¡£
2Â¥2010-08-10 14:13:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cuiwq456

ľ³æ (ÖøÃûдÊÖ)

ÇÀ¸öÀä°åµÊ
3Â¥2010-08-10 14:33:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

materyang

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¸øÀÏÍâ¿´µ½
4Â¥2010-08-10 14:41:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
5Â¥2010-08-10 14:41:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mxtfirst

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
NSFÊÇÃÀ¹ú¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð°É
6Â¥2010-08-10 15:37:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bthgg

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ºÜ²»´íŶ Ó¢ÎĵĿ´²»¶® ºÙºÙ
7Â¥2010-08-10 15:39:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Çç¿Õ2721

Òø³æ (СÓÐÃûÆø)

¿´²»¶® ºÙºÙ
ÌìµÀ³êÇÚ
8Â¥2010-08-10 15:56:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

superdr

½ð³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
NSF£ºÃÀ¹ú¹ú¼Ò×ÔÈ»»ù½ð»á
9Â¥2010-08-10 16:43:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×£¸££¡£¡
10Â¥2010-08-10 17:07:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ johozhang µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 0XLacIJUOj8D 2026-08-24 8/400 2026-08-25 05:12 by BZKMTicpDhFj
[»ù½ðÉêÇë] Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡· +7 scalable 2026-08-24 7/350 2026-08-24 23:01 by anata1209
[»ù½ðÉêÇë] ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË +7 ͼÀ²Í¼À² 2026-08-24 8/400 2026-08-24 22:00 by maomao_da
[ÂÛÎÄͶ¸å] ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 0XLacIJUOj8D 2026-08-24 3/150 2026-08-24 21:59 by BZKMTicpDhFj
[»ù½ðÉêÇë] ÎÒÃæÉÏÍêµ°ÁË +9 ÇÒÌý»¢Ð¥ 2026-08-20 10/500 2026-08-24 20:08 by ¿àº®À´Ïã
[»ù½ðÉêÇë] ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî +21 koalala 2026-08-24 24/1200 2026-08-24 19:25 by ¼ÒÓëÔ¶·½
[»ù½ðÉêÇë] ½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã +13 kulium 2026-08-21 16/800 2026-08-24 16:27 by superceng
[»ù½ðÉêÇë] ½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û +17 ҽѧÀÏÄк¢ 2026-08-20 21/1050 2026-08-24 14:21 by refreshing11
[»ù½ðÉêÇë] ¹À¼ÆÊÇÖÜËÄ +4 archvillain 2026-08-18 4/200 2026-08-24 13:53 by zzuzxg
[»ù½ðÉêÇë] ·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë +6 Ñ׻ƹóëÐ 2026-08-22 7/350 2026-08-24 11:58 by 6543yes
[»ù½ðÉêÇë] ÅóÓÑȦ¿´µ½µÄ +7 wangzilk 2026-08-18 9/450 2026-08-24 10:50 by cmrandy
[»ù½ðÉêÇë] ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡ +13 ´óƼ1987 2026-08-20 16/800 2026-08-24 10:23 by ̫ɵÁË
[»ù½ðÉêÇë] ·Å°ñǰµÄ²»µ­¶¨ 20+4 snowwithsea 2026-08-19 17/850 2026-08-24 10:20 by echo8914667
[»ù½ðÉêÇë] ¿ÆÑй¶ùÌ«ÄÑÁË +18 ÎÒ4´ó°×²Ë 2026-08-20 19/950 2026-08-24 09:47 by ¿­¶÷¹ãÊ¢´ß»¯·ÖÎ
[»ù½ðÉêÇë] 2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½ +4 process2012 2026-08-23 5/250 2026-08-23 19:58 by jurkat.1640
[»ù½ðÉêÇë] Ó¦¸ÃÊÇÏÂÖÜÈý26ÈÕ¹«²¼Á˰ɣ¿ +4 ¹þ¹þ¸ò£¿ 2026-08-21 4/200 2026-08-21 10:58 by Vivilian
[»ù½ðÉêÇë] ½ñÌì·Å°ñûϷÁ衃 +9 yuleib84 2026-08-19 11/550 2026-08-21 10:06 by gltch
[»ù½ðÉêÇë] »ù½ð°¡»ù½ð +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
[»ù½ðÉêÇë] Ã÷Ìì·Å°ñ£¿ +5 Shxjjxjkx 2026-08-18 5/250 2026-08-18 18:14 by -´ó´ó´ó´ó´ó-
[»ù½ðÉêÇë] ½ñÌìά»¤ÏµÍ³Î¬»¤ ×£ËùÓÐÈË ¸ßÖÐ +8 gjjjzhong 2026-08-18 9/450 2026-08-18 13:01 by ¼ÒÓëÔ¶·½
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û